Amplify Treatments, Testing and Advancements ETF (NYSEARCA:GERM – Get Free Report) shares rose 1.8% during trading on Monday . The company traded as high as $16.78 and last traded at $16.64. Approximately 2,910 shares changed hands during trading, an increase of 35% from the average daily volume of 2,151 shares. The stock had previously closed at $16.35.
Amplify Treatments, Testing and Advancements ETF Trading Down 1.3 %
The stock has a 50-day simple moving average of $17.92 and a 200 day simple moving average of $17.97. The company has a market cap of $9.17 million, a price-to-earnings ratio of 6.35 and a beta of 0.87.
About Amplify Treatments, Testing and Advancements ETF
The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is managed by ETF Managers Group.
See Also
- Five stocks we like better than Amplify Treatments, Testing and Advancements ETF
- What is Insider Trading? What You Can Learn from Insider Trading
- High-Yield Texas Instruments Could Hit New Highs Soon
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Stock Analyst Ratings and Canadian Analyst Ratings
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Amplify Treatments Testing and Advancements ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplify Treatments Testing and Advancements ETF and related companies with MarketBeat.com's FREE daily email newsletter.
